Cytokinetics (CYTK) Other Non Operating Income (2022 - 2026)
Cytokinetics (CYTK) posted quarterly Other Non Operating Income of $1.5 million for Q1 2026, up 475.0% year-over-year from $260869.6 in Q1 2025, and down 88.72% quarter-over-quarter from $13.3 million in Q4 2025.
Cytokinetics (CYTK) Other Non Operating Income (2022 - 2026) Analysis & Trends
Cytokinetics (CYTK) has reported Other Non Operating Income for 4 consecutive years, with $1.5 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Other Non Operating Income rose 475.0% year-over-year to $1.5 million; the TTM figure through Mar 2026 stood at $12.5 million (up 191.24% YoY), while the FY2025 annual figure was -$200000.0, up 98.98% from the prior year.
- Other Non Operating Income slipped to $1.5 million in Q1 2026 per CYTK's latest filing, from $13.3 million in the prior quarter.
- Across five years, Other Non Operating Income topped out at $13.3 million in Q4 2025 and bottomed at -$22.2 million in Q3 2022.
- Historically, Other Non Operating Income has averaged -$2.6 million across 4 years, with a median of $100000.0 in 2024.
- On a YoY basis, Other Non Operating Income climbed as much as 923.08% in 2025 and fell as far as 600.0% in 2025.
- Cytokinetics' Other Non Operating Income stood at -$22.2 million in 2022, then soared by 105.84% to $1.3 million in 2024, then jumped by 923.08% to $13.3 million in 2025, then sank by 88.72% to $1.5 million in 2026.
- Business Quant data shows CYTK's Other Non Operating Income at $1.5 million in Q1 2026, $13.3 million in Q4 2025, and $700000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Cytokinetics | 10.31 Bn | 9.14 Bn | 25.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.40 Mn |
| Mar 31, 2026 | 1.50 Mn |
| Dec 31, 2025 | 13.30 Mn |
| Sep 30, 2025 | 700,000.00 |
| Jun 30, 2025 | -3.00 Mn |
| Mar 31, 2025 | -400,000.00 |
| Dec 31, 2024 | 1.30 Mn |
| Sep 30, 2024 | -15.20 Mn |
| Jun 30, 2024 | 600,000.00 |
| Sep 30, 2022 | -22.25 Mn |
| Mar 31, 2022 | -2.69 Mn |